BC046331 Activators
BC046331 Activators encompass a diverse array of chemical compounds that function through different biochemical mechanisms to enhance the activity of BC046331. Forskolin and 8-Bromo-cAMP, by increasing intracellular cAMP levels, activate PKA, which in turn could phosphorylate BC046331, leading to its functional enhancement within the cell. Similarly, Phorbol 12-myristate 13-acetate (PMA) and Bisindolylmaleimide I, through modulation of PKC activity, may induce a reorganization of the cellular phosphorylation landscape that includes BC046331, thereby amplifying its action. Calcium ionophores like Ionomycin and A23187 elevate intracellular calcium levels, potentially activating calcium-dependent protein kinases that can phosphorylate BC046331, increasing its activity. The influence of insulin, through the PI3K/Akt pathway, and the compensatory effects of PI3K inhibitor LY294002, may also indirectly augment the activity of BC046331 by affecting its phosphorylation state.
Moreover, All-trans Retinoic Acid has the capacity to modulate gene expression and possibly the activity of associated proteins, including BC046331. Okadaic Acid prevents the dephosphorylation of proteins by inhibiting protein phosphatases, thereby maintaining BC046331 in an active phosphorylated state. Epigallocatechin Gallate (EGCG) can influence kinase activity and cellular signaling pathways, which may lead to an indirect enhancement ofBC046331 activity. Lastly, the essential trace element Zinc may contribute to the stabilization and activation of BC046331 by acting as a cofactor, reinforcing its structural integrity and function within various biochemical pathways. Collectively, these BC046331 Activators work through distinct yet convergent mechanisms, orchestrating a cellular environment conducive to the phosphorylation, stabilization, and overall activation of BC046331 without the need for increased gene expression or direct ligand-based activation.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA acts as a potent activator of protein kinase C (PKC). PKC phosphorylates a variety of protein targets, potentially including BC046331, thereby enhancing its activity within cellular signaling pathways. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin is a calcium ionophore that increases intracellular calcium levels. Elevated calcium can activate calcium-dependent protein kinases, which may phosphorylate and enhance the activity of BC046331. | ||||||
Insulin | 11061-68-0 | sc-29062 sc-29062A sc-29062B | 100 mg 1 g 10 g | $156.00 $1248.00 $12508.00 | 82 | |
Insulin can activate the PI3K/Akt signaling pathway, leading to the phosphorylation of various downstream targets. Activation of this pathway could indirectly enhance the functional activity of BC046331 by modifying its state of phosphorylation. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
All-trans retinoic acid acts on retinoic acid receptors and may modulate gene expression profiles. It could influence the signaling pathways in which BC046331 is involved, thereby enhancing its activity. | ||||||
Bisindolylmaleimide I (GF 109203X) | 133052-90-1 | sc-24003A sc-24003 | 1 mg 5 mg | $105.00 $242.00 | 36 | |
This compound is a selective PKC inhibitor; however, its effect on the equilibrium of kinase activity can lead to compensatory activation of alternative pathways that may indirectly enhance the activity of BC046331. | ||||||
Okadaic Acid | 78111-17-8 | sc-3513 sc-3513A sc-3513B | 25 µg 100 µg 1 mg | $291.00 $530.00 $1800.00 | 78 | |
Okadaic acid is a potent inhibitor of protein phosphatases PP1 and PP2A, leading to increased phosphorylation levels within the cell. This can result in the enhanced activity of proteins like BC046331 through reduced dephosphorylation. | ||||||
8-Bromoadenosine 3′,5′-cyclic monophosphate | 23583-48-4 | sc-217493B sc-217493 sc-217493A sc-217493C sc-217493D | 25 mg 50 mg 100 mg 250 mg 500 mg | $108.00 $169.00 $295.00 $561.00 $835.00 | 2 | |
As a cAMP analog, 8-Bromo-cAMP can activate PKA and mimic the effects of cAMP within the cell. Activation of PKA can increase the phosphorylation and potential activity of BC046331. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $55.00 $131.00 $203.00 $317.00 | 23 | |
A23187 is a calcium ionophore similar to ionomycin that increases intracellular calcium levels, which could activate kinases that phosphorylate and enhance BC046331 activity. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is a PI3K inhibitor that can alter the balance of kinase activities in the PI3K/Akt pathway, potentially leading to the activation of compensatory mechanisms that enhance BC046331 activity. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
EGCG is a catechin found in green tea with kinase inhibitory properties. It may alter cellular signaling pathways and indirectly increase the functional activity of BC046331. | ||||||